海利尔药业集团股份有限公司 （1）最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法 表示意见的审计报告； （2）最近一个会计年度财务报告内部控制被注册会计师出具否定意见或者 无法表示意见的审计报告； （3）上市后最近 36 个月内出现过未按法律法规、公司章程、公开承诺进行 利润分配的情形； （4）法律法规规定不得实行股权激励的； （5）中国证监会认定的其他情形。 2、限制性股票激励计划所确定的激励对象不存在《管理办法》规定的不得 成为激励对象的情形： （1）最近 12 个月内被证券交易所认定为不适当人选； （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； 董事会薪酬与考核委员会关于 2025 年限制性股票激 励计划相关事项的核查意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共 和国证券法》（以下简称"《证券法》"）《上市公司股权激励管理办法》（以 下简称"《管理办法》"）等有关法律、法规、部门规章及规范性文件和《公司 章程》的规定，海利尔药业集团股份有限公司（以下简称"公司"）董事会薪酬 与考核委员会对公司 2025 年限制性股票激励计划（以下简称"限制性 ...

海利尔药业集团股份有限公司 2025 年限制性股票激励计划 实施考核管理办法 为保证海利尔药业集团股份有限公司（以下简称"海利尔"、"本公司"或"公 司"）为进一步完善公司法人治理结构，建立、健全公司长效激励约束机制，吸 引和留住优秀人才，充分调动其积极性和创造性，有效提升核心团队凝聚力和企 业核心竞争力，有效地将股东、公司和核心团队三方利益结合在一起，使各方共 同关注公司的长远发展，确保公司发展战略和经营目标的实现，在充分保障股东 利益的前提下，按照激励与约束对等的原则，制定了《海利尔药业集团股份有限 公司 2025 年限制性股票激励计划（草案）》（以下简称"本激励计划"）。 为保证公司本激励计划的顺利推进及有序实施，现根据《中华人民共和国公 司法》 《中华人民共和国证券法》 《上市公司股权激励管理办法》 《上海证 券交易所股票上市规则》等有关法律、行政法规、规范性文件和《公司章程》的 有关规定，并结合公司实际情况，特制订《海利尔药业集团股份有限公司 2025 年限制性股票激励计划实施考核管理办法》（以下简称"本办法"）。 一、考核目的 制定本办法的目的是加强本激励计划执行的计划性，量化本激励计划设定的 具 ...

证券简称：海利尔 证券代码：603639 海利尔药业集团股份有限公司 2025年限制性股票激励计划 （草案） 三、本激励计划拟授予激励对象的限制性股票数量为 1,250.00 万股，约占 本激励计划草案公布日公司股本总额 33,987.8336 万股的 3.68%。其中，首次 授予限制性股票 1,150.00 万股，约占本激励计划草案公布日公司股本总额 1 海利尔药业集团股份有限公司 二○二五年九月 声明 本公司及全体董事保证本激励计划及其摘要不存在虚假记载、误导性陈述或 重大遗漏，并对其真实性、准确性、完整性承担个别和连带的法律责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或行使权益安排的，激励对象应当自相关信 息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激励计划 所获得的全部利益返还公司。 特别提示 一、2025年限制性股票激励计划(以下简称"本激励计划"）是依据《中华 人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以 下简称《证券法》）、中国证券监督管理委员会《上市公司股权激励管理办法》 （以下简称"《 ...

2025 年限制性股票激励计划（草案）的 法律意见书 致：海利尔药业集团股份有限公司 北京市金杜（青岛）律师事务所（以下简称金杜或本所）接受海利尔药业集团 股份有限公司（以下简称海利尔或公司）委托，作为其实施 2025 年股票期权激励 计划（以下简称本激励计划、本次激励计划或本计划）的专项法律顾问，根据《中 华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简 称《证券法》）、中国证券监督管理委员会（以下简称中国证监会）《上市公司股权 激励管理办法》（以下简称《管理办法》）、《上海证券交易所股票上市规则》（以下 简称《上市规则》）、《上海证券交易所上市公司自律监管指南第 2 号——业务办理》 （以下简称《业务办理指南》）等法律、行政法规、部门规章及规范性文件（以下 简称法律法规）和《海利尔药业集团股份有限公司章程》（以下简称《公司章程》） 的有关规定，就公司实施本次激励计划所涉及的相关事项，出具本法律意见书。 为出具本法律意见书，金杜依据《律师事务所从事证券法律业务管理办法》和 《律师事务所证券法律业务执业规则（试行）》等有关规定，收集了相关证据材料， 查阅了按规定需要查阅的文件以及金 ...

Core Viewpoint - Hailier (603639.SH) has disclosed a draft for its 2025 restricted stock incentive plan, proposing to grant 12.5 million restricted shares, which accounts for approximately 3.68% of the company's total share capital as of the announcement date [1] Summary by Sections - The number of restricted shares to be granted is 12.5 million [1] - The initial grant consists of 11.5 million restricted shares [1] - A total of 618 individuals will receive the initial grant [1] - The grant price is set at 7.28 yuan per share [1]

智通财经APP讯，海利尔(603639.SH)披露2025年限制性股票激励计划(草案)，拟授予激励对象的限制性 股票数量为1250万股，约占激励计划草案公布日公司股本总额的3.68%。其中，首次授予限制性股票 1150万股，首次授予激励对象共计618人，授予价格为7.28元/股。 ...

格隆汇9月29日｜海利尔公告，公司股东青岛合意投资中心（有限合伙）减持计划时间区间为2025年6月 27日至2025年9月26日，已通过集中竞价累计减持44.76万股，占公司总股本的0.1317%，减持价格区间 13.72～15.75元/股，套现632.78万元；其当前持股1720.46万股，占5.0620%。 ...

Core Points - The article discusses the administrative penalty imposed on Hailir Pharmaceutical Group Co., Ltd. by the Yangshan Customs for violating customs regulations [1][2][6] - The company was found to have misdeclared the contents of an export shipment to Cambodia, which included various pesticides that required specific export documentation [1][4][6] - A fine of 113,000 RMB was levied against the company for these violations [2][7] Summary by Sections Violation Details - Hailir Pharmaceutical Group declared an export of 14,000 kg of a solution containing 3% benzylaminopurine and 3% gibberellin A3, with a total declared value of 159,800 USD [1][4] - The actual shipment included several pesticides, such as imidacloprid and avermectin, which were not properly documented for export [1][4][6] Financial Implications - The total value of the misdeclared goods was calculated to be approximately 1,139,833.84 RMB [2][5] - The imposed fine for the violation amounts to 113,000 RMB [2][7] Company Background - Hailir Pharmaceutical Group, established in 1999, is a state-designated manufacturer of pesticides and fertilizers, and it went public on the Shanghai Stock Exchange in 2017 [8]

Investment Rating - The industry investment rating is maintained as "Positive" [5] Core Viewpoints - The "Stabilizing Growth Work Plan" for the petrochemical industry has raised expectations, focusing on enhancing technological innovation, expanding effective investment, and fostering market demand [8] - The green low-carbon industry, particularly green polyester, is expected to experience rapid growth due to new technologies and significant market potential [8] Summary by Sections Investment Recommendations and Targets - The report favors companies that have strategically positioned themselves in the green polyester sector, such as Wankai New Materials (301216, Buy). Other recommended stocks include Sinopec (600028, Buy), Hengli Petrochemical (600346, Buy), Rongsheng Petrochemical (002493, Buy), Wanhua Chemical (600309, Buy), and Huayi Group (600623, Buy). Additionally, companies in the pesticide formulation segment like Runfeng Co., Ltd. (301035, Buy), Guoguang Co., Ltd. (002749, Buy), and Hailier (603639, Buy) are also highlighted [3] Industry Overview - The petrochemical industry is currently facing significant oversupply, making rapid recovery through market-driven policies challenging. However, the long-term outlook for the industry is improving, with lower valuations for leading chemical stocks providing good investment opportunities [8] - The green low-carbon sector, including green methanol, bio-aviation fuel, and green polyester, is gaining market attention due to its vast market space and the need for sustainable development. Companies that capitalize on these trends are expected to achieve rapid growth [8] Recent Developments - The recent "Stabilizing Growth Work Plan" emphasizes controlling new refining capacity and supporting key products in electronic chemicals and high-end polyolefins, while also fostering new application scenarios in emerging fields like renewable energy and low-altitude economy [8]

Core Viewpoint - The company has decided to cancel its supervisory board and amend its articles of association due to the disqualification of six incentive targets from the 2021 restricted stock incentive plan, leading to the repurchase and cancellation of 20,000 unvested restricted shares [1]. Group 1 - The company held its eighth meeting of the fifth board of directors on April 28, 2025, where the proposal to cancel the supervisory board was approved [1]. - The total share capital of the company will decrease from 339,898,336 shares to 339,878,336 shares, and the registered capital will change from 339,898,336 yuan to 339,878,336 yuan [1]. - The company has completed the business registration change and obtained a new business license from the Qingdao Administrative Approval Service Bureau [1]. Group 2 - The company is classified as a listed other joint-stock company, with its registered address in the Chengdong Industrial Park, Chengyang District, Qingdao [1]. - The company was established on December 1, 1999, and its business scope includes the production and sale of water-soluble fertilizers and pesticides, as well as various other services related to agriculture and technology [1].